This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Eosinophilic endomyocardial disease

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Eosinophilic endomyocardial disease is characterized by:

  • endomyocardial fibrosis
  • a high incidence at temperate latitudes
  • large mural thrombi
  • eosinophilia with infiltration of organs especially the heart (causing restrictive cardiomyopathy)
  • rapid fatality

This disease is closely related to the African condition of endomyocardial fibrosis (qv).

Treatment measures include:

  • suppression of eosinophilia e.g. prednisolone or hydroxycarbamide (former British Approved Name, hydroxyurea)
  • digoxin
  • diuretics

Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page